Structures by: Gorczyński A.
Total: 17
C17H15Cl4Fe2N3O
C17H15Cl4Fe2N3O
New Journal of Chemistry (2019) 43, 32 12650
a=7.7796(3)Å b=15.2532(6)Å c=17.3510(7)Å
α=90° β=93.908(4)° γ=90°
2(C17H15Cl2FeN3),2(Cl4Fe),C7H8
2(C17H15Cl2FeN3),2(Cl4Fe),C7H8
New Journal of Chemistry (2019) 43, 32 12650
a=8.31307(9)Å b=31.0196(3)Å c=9.76421(10)Å
α=90° β=96.5938(10)° γ=90°
C32H38Cl2N8O9.5
C32H38Cl2N8O9.5
RSC Adv. (2016)
a=11.4426(5)Å b=13.0011(5)Å c=24.5126(10)Å
α=90.991(3)° β=91.953(4)° γ=92.005(4)°
C60H74Fe2N16O6,4(ClO4)
C60H74Fe2N16O6,4(ClO4)
RSC Adv. (2016)
a=10.6236(17)Å b=13.530(2)Å c=16.128(2)Å
α=66.459(15)° β=87.591(12)° γ=78.066(14)°
C84H87Ho2N24O3,3(NO3)
C84H87Ho2N24O3,3(NO3)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 38 16833-16839
a=26.1368(10)Å b=26.1368(10)Å c=48.150(2)Å
α=90° β=90° γ=120°
C84H87Dy2N24O3,3(NO3)
C84H87Dy2N24O3,3(NO3)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 38 16833-16839
a=26.1377(11)Å b=26.1377(11)Å c=47.2565(16)Å
α=90° β=90° γ=120°
C84H87N24O3Yb2,3(NO3)
C84H87N24O3Yb2,3(NO3)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 38 16833-16839
a=25.9543(5)Å b=25.9543(5)Å c=48.9988(13)Å
α=90° β=90° γ=120°
C84H87N24O3Tm2,3(NO3)
C84H87N24O3Tm2,3(NO3)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 38 16833-16839
a=26.1210(5)Å b=26.1210(5)Å c=47.7029(13)Å
α=90° β=90° γ=120°
C84H87Er2N24O3,3(NO3)
C84H87Er2N24O3,3(NO3)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 38 16833-16839
a=26.1100(7)Å b=26.1100(7)Å c=48.0953(13)Å
α=90° β=90° γ=120°
2-[(2<i>E</i>)-2-(1<i>H</i>-Imidazol-4-ylmethylidene)-1-methylhydrazinyl]pyridine
C10H11N5
Acta Crystallographica Section C (2020) 76, 4 367-374
a=10.1953(4)Å b=14.2866(5)Å c=14.9027(5)Å
α=90° β=103.845(3)° γ=90°
5-{(1<i>E</i>)-[2-(1<i>H</i>-1,3-Benzodiazol-2-yl)-2-methylhydrazinylidene]methyl}-1<i>H</i>-imidazol-3-ium trifluoromethanesulfonate monohydrate
C12H13N6,CF3O3S,H2O
Acta Crystallographica Section C (2020) 76, 4 367-374
a=8.9818(5)Å b=9.5704(5)Å c=21.1278(12)Å
α=90° β=95.383(5)° γ=90°
2-{(2<i>E</i>)-1-Methyl-2-[(1<i>H</i>-imidazol-3-ium-2-yl)methylidene]hydrazinyl}pyridinium bis(trifluoromethanesulfonate)
C10H13N52,2(CF3O3S)
Acta Crystallographica Section C (2020) 76, 4 367-374
a=12.2524(5)Å b=14.0242(5)Å c=11.4488(5)Å
α=90° β=102.259(4)° γ=90°
2-{(2<i>E</i>)-1-Methyl-2-[(1-methyl-1<i>H</i>-imidazol-2-yl)methylidene]hydrazinyl}-1<i>H</i>-benzimidazole hydrate
4(C13H14N6),5(H2O)
Acta Crystallographica Section C (2020) 76, 4 367-374
a=9.1836(3)Å b=16.5814(4)Å c=20.8041(6)Å
α=106.760(2)° β=97.854(2)° γ=103.408(2)°
C84H87N24O3Tb2,3(NO3)
C84H87N24O3Tb2,3(NO3)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 38 16833-16839
a=26.2088(6)Å b=26.2088(6)Å c=48.2544(11)Å
α=90° β=90° γ=120°
C12H16N8O10Yb,C2H4N
C12H16N8O10Yb,C2H4N
Inorganic Chemistry Frontiers (2018) 5, 3 605
a=8.1752(5)Å b=11.5352(9)Å c=13.1045(10)Å
α=66.989(7)° β=72.978(6)° γ=85.535(5)°
C11H15ErN8O10
C11H15ErN8O10
Inorganic Chemistry Frontiers (2018) 5, 3 605
a=8.3705(7)Å b=9.3039(7)Å c=12.7182(9)Å
α=102.222(6)° β=103.692(7)° γ=102.763(6)°
C24H26F6N10O6S2Yb,CF3O3S
C24H26F6N10O6S2Yb,CF3O3S
Inorganic Chemistry Frontiers (2018) 5, 3 605
a=11.3018(5)Å b=13.3845(6)Å c=14.5613(4)Å
α=96.292(3)° β=99.214(3)° γ=107.796(4)°